- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05054049
Point of Care Testing for Advanced Practitioners (Paramedics) (POCTPara)
Point of Care Testing (POCT) for Advanced Practitioners (Paramedics) in Urgent and Emergency Care: a Single Site Feasibility Study
Point of care testing (POCT) is described as a laboratory test conducted near the patient with a rapid result obtained through a portable analysing device, as opposed to the collection of a blood sample being transferred to a central laboratory for analysis and reporting.
Over the past 15 years increasing emphasis has been placed upon the paramedic profession as a possible solution to addressing the increasing demands placed on emergency departments. This is largely viewed through the ability of paramedics to assess patients calling 999 and manage a patient's condition away from the emergency department, with sufficient evidence supporting the role of the paramedic to develop competencies to manage larger volumes of patients.
This feasibility study will seek to understand whether paramedics report that the use of POCT devices is useful in safe clinical decision making with patients in the community, and if it is possible to use the Abbott i-STAT device in the urgent and emergency care setting for those patients where management within the community is being considered.
Given that there is very little evidence in this subject area, the research should start to inform the potential for future innovations in paramedic and community practice, and build on the body of evidence regarding POCT by paramedics related to community management.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Andrew Hodge
- Phone Number: +447798640414
- Email: andrew.hodge1@nhs.net
Study Contact Backup
- Name: Bryan Lightowler
- Email: b.lightowler@bradford.ac.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Paramedic Participants
Inclusion criteria:
- HCPC registered paramedics employed as advanced practitioners
- From the selected advanced practitioner team (Sheffield)
- Able to provide informed consent
- Willing to undergo training and to deliver intervention
- Willing to undergo training to participate in study measures and processes
- Willing to take part in the focus group
Patient Participants
Inclusion criteria:
- Adult patients aged 18 years old and over.
- Registered with a GP Surgery in the Sheffield CCG boundary.
- In their normal home environment, care home, nursing home or step up intermediate bed service, experiencing an ambulatory sensitive presentation related to falls, frailty, mild to moderate breathlessness, or non-specific general illness and receiving an ambulance service response from participating advanced practitioners (paramedics).
- Who do not require immediate life-saving intervention/immediate transfer to ED.
- Able to give written consent during the call-out.
Exclusion Criteria:
-
Paramedic Participants:
• Any HCPC registered advanced practitioner (paramedic) who is currently under investigation for fitness to practice.
Patient Participants
- Patients requiring emergency intervention and immediate transfer to hospital.
- Patient does not have mental capacity.
- Clinical presentations that should not have any delayed on scene time, meeting the criteria outlined in the YAS policy for the assessment, conveyance and referral of patients, for example detailing the NEWS2 score and other appropriate clinical screening tools that assist in the decision making regarding the decision to convey or refer for community management.
- Non-English speaking patients.
- End of life care patients.
- Patients residing in prison.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Abbott i-stat Allinity
Randomised patients to this arm receive the application of the point of care testing device to provide further diagnostic information to assist clinical decision making.
|
Point of care testing venous blood diagnostic device.
Other Names:
|
|
Placebo Comparator: Usual Care
Randomised patients to this arm receive usual care.
|
Usual care provided to patient without use of point of care testing device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported impact of using POCT device
Time Frame: 1.5 hours focus group at end of study
|
Qualitative focus group data measuring perceived self-reported impact by advanced practitioner (paramedic).
|
1.5 hours focus group at end of study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Non-conveyance rate
Time Frame: Through study completion, expected to be 6 months
|
Proportion of cases not conveyed to hospital
|
Through study completion, expected to be 6 months
|
|
72 hour re-contact rate
Time Frame: Through study completion, expected to be 6 months
|
Proportion of non-conveyed hospital where there was a re-contact to the ambulance service
|
Through study completion, expected to be 6 months
|
|
Type of POCT cartridges used.
Time Frame: During the procedure
|
Type of POCT cartridges used.
|
During the procedure
|
|
Number of POCT cartridges used.
Time Frame: During the procedure
|
Number of POCT cartridges used.
|
During the procedure
|
|
Number of successful and unsuccessful attempts in using the POCT device.
Time Frame: During the procedure
|
Number of successful and unsuccessful attempts in using the POCT device recorded as a measurement of failure rates
|
During the procedure
|
|
Length of time on scene.
Time Frame: immediately after the patient care episode has ended
|
Understanding any changes to time spent with patient
|
immediately after the patient care episode has ended
|
|
Number of patients who receive POCT.
Time Frame: Through study completion, expected to be 6 months
|
Descriptive data to understand how many patients were eligible for the POCT device
|
Through study completion, expected to be 6 months
|
|
Patient demographics and presentations where POCT is applied - age, gender, NEWS2 score, clinical condition.
Time Frame: Through study completion, expected to be 6 months
|
Descriptive data to understand patient characteristics of those patients enrolled into study
|
Through study completion, expected to be 6 months
|
|
Feasibility of patient randomisation process
Time Frame: Through study completion, expected to be 6 months
|
Descriptive data to record number of successful and unsuccessful attempts at randomisation of eligible patients
|
Through study completion, expected to be 6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Andrew Hodge, Yorkshire Ambulance Service
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YASRD148
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Point of Care Testing
-
Research Unit Of General Practice, CopenhagenUniversity of Copenhagen; Region Capital Denmark; The Copenhagen General Practice... and other collaboratorsCompleted
-
Research Unit Of General Practice, CopenhagenUniversity of Copenhagen; Region Capital Denmark; The Copenhagen General Practice... and other collaboratorsCompleted
-
Central Denmark RegionRecruitingPoint of Care Testing | Prehospital Emergency Medical Services | Prehospital Emergency CareDenmark
-
Umeå UniversityCompletedCardiopulmonary Bypass | Blood Coagulation | Point-of-Care TestingSweden
-
Johann Wolfgang Goethe University HospitalCompletedClot Formation and Platelet Aggregation in Point of Care TestingGermany
-
Helen Joseph HospitalUniversity of Johannesburg; Abbott Point of Care; Lodox Systems (Ltd)CompletedEmergency Medicine | Point-of-Care TestingSouth Africa
-
Centre Hospitalier Universitaire, AmiensRecruitingAnastomotic Leak | Colorectal Surgery | Enhanced Recovery | Post-operative Complication | CRP Point-of-care Testing TrajectoryFrance
-
National Taiwan University HospitalNot yet recruiting
-
University Health Network, TorontoNot yet recruiting
-
National Taiwan University HospitalCompletedPoint-of-care UltrasoundTaiwan
Clinical Trials on Interventional Diagnostic Device Arm
-
Ages et Vies AssociationCaisse Nationale de Solidarité pour l'Autonomie; National Insurance Fund Vieilleisse and other collaboratorsCompleted
-
Northwestern UniversityCompleted
-
Ottawa Heart Institute Research CorporationCanadian Institutes of Health Research (CIHR); AbbottRecruitingAtrial Fibrillation | Radiofrequency Catheter Ablation | Catheter AblationCanada
-
Kaiser Clinic and HospitalCompleted
-
Instituto de Investigacion Sanitaria La FeMedtronicUnknown
-
Hospital Pedro HispanoUnknownBleeding After Resection of Colorectal Neoplastic LesionsPortugal
-
Assiut UniversityNot yet recruitingLower Limb Ischemia Critical
-
AstraZenecaQuintiles, Inc.Completed
-
Istituto Scientifico Romagnolo per lo Studio e...Completed
-
Rabin Medical CenterTerminated